Posted in | News | Medical Robotics

UHO Incorporates CyberKnife Robotic Radiosurgery System

Accuray Incorporated has declared that University Hospital of Ostrava (UHO) Clinic of Oncology has incorporated its CyberKnife robotic system for cancer treatment and has become the first Medical center in Czech Republic to include robotic surgery in cancer treatment.

CyberKnife Robotic Radiosurgery System

The UHO academic unit has included this robotic system in an exclusive building, thereby enhancing its oncology department. CyberKnife enables UHO to widen their treatment options by precisely offering high dosage of radiation and completing the treatment within a few sessions. The hospital is focused on treating tumors located outside the cranium including prostate, liver and lungs.

David Feltl, Head of the Oncology Clinic at the UHO has stated that by including the CyberKnife robotic system they can treat those tumors which cannot be easily dealt with conventional surgical methods due to any of the factors including size, shape or nearness of the tumor cells to major organs or tissues, patient’s physiological conditions etc.

Vittorio Puppo, General Manager, Accuray EIMEA (Europe, India, Middle East and Africa) expressed his pleasure in introducing CyberKnife to the Czech Republic and he added that this new incorporation facilitates cancer patients to easily avail CyberKnife treatment thereby serving as a supplementary treatment method for those who were not given any therapy options till date.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.